CHIARLE, Roberto

CHIARLE, Roberto  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 20 di 155 (tempo di esecuzione: 0.028 secondi).
Titolo Data di pubblicazione Autore(i) File
A Braf kinase-inactive mutant induces lung adenocarcinoma 2017 Nieto P.; Ambrogio C.; Esteban-Burgos L.; Gomez-Lopez G.; Blasco M.T.; Yao Z.; Marais R.; Rosen N.; Chiarle R.; Pisano D.G.; Barbacid M.; Santamaria D.
A LIBRETTO to orchestrate targeted therapy 2020 Marmarelis, Melina E; Chiarle, Roberto; Ambrogio, Chiara; Aggarwal, Charu
A theranostic approach based on the use of a dual boron/Gd agent to improve the efficacy of Boron Neutron Capture Therapy in the lung cancer treatment 2015 Alberti, Diego; Protti, Nicoletta; Toppino, Antonio; Deagostino, Annamaria; Lanzardo, Stefania; Bortolussi, Silva; Altieri, Saverio; Voena, Claudia; Chiarle, Roberto; Geninatti Crich, Simonetta; Aime, Silvio
Ablation of oncogenic ALK is a viable therapeutic approach fAblation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas 2006 PIVA R; CHIARLE R; MANAZZA AD; TAULLI R; SIMMONS W; AMBROGIO C; D'ESCAMARD V; PELLEGRINO E; PONZETTO C; PALESTRO G; INGHIRAMI G
Advances in cancer immunology and cancer immunotherapy 2016 Voena, Claudia*; Chiarle, Roberto
ALK inhibitors and vaccination against anaplastic lymphoma kinase (ALK) induce potent anti-tumor activity improving survival in non small cell lung carcinoma (NSCLC) 2012 C. Voena; M. Menotti; C. Mastini; F. Di Giacomo; D.L. Longo; C. Martinengo; S. Aime; F. Cavallo; G. Inghirami; R. Chiarle
ALK protein tyrosine kinase, cells and methods embodying and using same 2005 R. Chiarle; G. Inghirami
ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis 2014 Martinengo, Cinzia; Poggio, Teresa; Menotti, Matteo; Scalzo, Maria Stella; Mastini, Cristina; Ambrogio, Chiara; Pellegrino, Elisa; Riera, Ludovica; Piva, Roberto; Ribatti, Domenico; Pastorino, Fabio; Perri, Patrizia; Ponzoni, Mirco; Wang, Qi; Voena, Claudia; Chiarle, Roberto
An In vivo Model of Met-Driven Lymphoma as a Tool to Explore the Therapeutic Potential of Met Inhibitors 2008 P. ACCORNERO; G. LATTANZIO; T. MANGANO; R. CHIARLE; R. TAULLI; F. BERSANI; P.E. FORNI; S. MIRETTI; C. SCUOPPO; W. DASTRU; J. CHRISTENSEN; T. CREPALDI; C. PONZETTO
An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma associated antigen 2009 P. Cappello; B Tomaino; R. Chiarle; P. Ceruti; A. Novarino; C. Castagnoli; P. Migliorini; G. Perconti; A. Giallongo; M. Milella; V. Monsurrò; S. Barbi; A. Scarpa; P. Nisticò; M. Giovarelli; F. Novelli
Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma? 2009 Fornari A; Piva R; Chiarle R; Novero D; Inghirami G
Anaplastic large-cell lymphoma 2011 Inghirami G; Pileri SA; Chiarle R; Cuccuru G; Martinoglio B; Medico E; Pellegrino E; Piva R; Ruberto ML; Fornari A; Novero D; Chilosi M; Zamó A; Facchetti F; Lonardi S; De Chiara A; Fulciniti F; Doglioni C; Ponzoni M; Agnelli L; Neri A; Todoerti K; Agostinelli C; Piccaluga PP; Falini B; Tiacci E; Van Loo P; Tousseyn T; De Wolf-Peeters C; Geissinger E; Muller-Hermelink HK; Rosenwald A; Piris MA; Rodriguez ME.
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death 2002 ZAMO A; R. CHIARLE; PIVA R; HOWES J; FAN Y; CHILOSI M; LEVY DE; INGHIRAMI G.
Anaplastic Lymphoma Kinase is an effective oncoantigen for lymphoma vaccination 2007 R. Chiarle; G. Inghirami; G. Forni
Anaplastic lymphoma kinase: an oncogene for tumor vaccination 2009 Mastini C; Martinengo C; Inghirami G; Chiarle R.
Argyrophilic nucleolar organizer region counts predict survival in thymoma. 1994 PICH A ;CHIARLE R ;CHIUSA L ;PALESTRO G
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. 2013 Capello M; Cappello P; Linty FC; Chiarle R; Sperduti I; Novarino A; Salacone P; Mandili G; Naccarati A; Sacerdote C; Beghelli S; Bersani S; Barbi S; Bassi C; Scarpa A; Nisticò P; Giovarelli M; Vineis P; Milella M; Novelli F.
Autoantibody signature in human ductal pancreatic adenocarcinoma 2007 TOMAINO B; CAPPELLO P; CAPELLO M; FREDOLINI C; PONZETTO A; NOVARINO A; CIUFFREDA L; BERTETTO O; ANGELIS CD; GAIA E; SALACONE P; MILELLA M; NISTICO P; ALESSIO M; CHIARLE R; GIUFFRIDA MG; GIOVARELLI M; NOVELLI F
BRAF gene is not mutated in plasma cell leukemia and multiple myeloma 2003 BONELLO L; VOENA C; LADETTO M; BOCCADORO M; PALESTRO G; INGHIRAMI G; R. CHIARLE
Calming down T cell acute leukemia. 2012 Hirsch E;Chiarle R